JBIO FY 2022 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$68,000

Operating Income

-$53M

Net Income

-$52M

EPS (Diluted)

$-73.67

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$39M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$135M

Total Liabilities

$9M

Stockholders' Equity

$127M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$68,000	-$15,000	-353.3%
Operating Income	-$53M	-$23M	-131.2%
Net Income	-$52M	-$23M	-124.3%